1. | 49n4na | |
2. | hawktalkin | |
3. | cmarquezu | |
4. | trussdog641 |
1. | 49n4na | |
2. | hawktalkin | |
3. | cmarquezu | |
4. | trussdog641 |
1. | cmarquezu 03/26/2018 Receives Paragraph IV certification notice letter regarding an ANDA submitted to the FDA by Teva (TEVA) requ… |
2. | 49n4na 02/14/2018 More Earnings out |
3. | 49n4na 02/14/2018 Beats EPS estimates by $0.09 and slightly beats on revenues |
4. | hawktalkin 03/05/2018 Announces that HETLIOZ demonstrated significant and clinically meaningful benefits in nighttime and daytim… |
5. | 49n4na 03/14/2018 Intends to offer and sell shares of its common stock in an underwritten public offering; size not disclosed |
6. | 49n4na 03/05/2018 HETLIOZ® (tasimelteon) Demonstrates Efficacy to Treat Jet Lag Disorder in an 8 Hour Phase Advance Clinical Study |